Aedes aegypti mosquito saliva ameliorates acetaminophen-induced liver injury in mice
Open Access
- 8 February 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2) , e0245788
Abstract
Acetaminophen (N-acetyl-p-aminophenol, APAP) overdose is the most common cause of drug-induced liver injury (DILI). Although the primary hepatic damage is induced by APAP-derived toxic intermediates resulting from cytochrome P450 metabolism, immune components also play an important role in DILI pathophysiology.Aedes aegyptisaliva is a source of bioactive molecules within vitroanti-inflammatory and immunomodulatory activities. However, evidences on the therapeutic use ofAe.aegyptisalivary preparations in animal models of relevant clinical conditions are still scarce. Thus, the present study was designed to evaluate the protective role ofAe.aegyptisaliva in a murine model of APAP-induced DILI. C57BL/6 mice were exposed toAe.aegyptibites 2 hours after APAP overdose. Biochemical and immunological parameters were evaluated in blood and liver samples at different time points after APAP administration. Exposure toAe.aegyptisaliva attenuated liver damage, as demonstrated by reduced hepatic necrosis and serum levels of alanine aminotransferase in APAP-overdosed mice. The levels of hepatic CYP2E1, the major enzyme responsible for the bioactivation of APAP, were not changed inAe.aegyptiexposed animals, suggesting no effects in the generation of hepatotoxic metabolites. On the other hand, mice treated withAe.aegyptisaliva following APAP overdose presented lower serum concentration of TNF-α, IL-6, IL-1β and IL-10, as well as reduced frequency of inflammatory cell populations in the liver, such as NKT cells, macrophages and dendritic cells. These findings show thatAe.aegyptisaliva has bioactive molecules with therapeutic properties and may represent a prospective source of new compounds in the management of DILI-associated inflammatory disorders and, perhaps, many other inflammatory/autoimmune diseases.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Code 001)
- Instituto Nacional de Ciência e Tecnologia em Entomologia Molecular - CNPq (465678/2014-9)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2009/09892-6)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2016/11523-2)
- Núcleo de Pesquisa em Moléculas Bioativas de Artrópodes Vetores (12.1.17661.1.7)
This publication has 59 references indexed in Scilit:
- Effects of Aedes aegypti salivary components on dendritic cell and lymphocyte biologyParasites & Vectors, 2013
- The Tick Salivary Protein Sialostatin L Inhibits the Th9-Derived Production of the Asthma-Promoting Cytokine IL-9 and Is Effective in the Prevention of Experimental AsthmaThe Journal of Immunology, 2012
- The protein LJM 111 from Lutzomyia longipalpis Salivary Gland Extract (SGE) accounts for the SGE-inhibitory effects upon inflammatory parameters in experimental arthritis modelInternational Immunopharmacology, 2012
- Nucleosides from Phlebotomus papatasi Salivary Gland Ameliorate Murine Collagen-Induced Arthritis by Impairing Dendritic Cell FunctionsThe Journal of Immunology, 2011
- Dendritic cell depletion exacerbates acetaminophen hepatotoxicityHepatology, 2011
- Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunityLiver International, 2011
- The Immunomodulatory Action of Sialostatin L on Dendritic Cells Reveals Its Potential to Interfere with AutoimmunityThe Journal of Immunology, 2009
- SAAG‐4 is a novel mosquito salivary protein that programmes host CD4+ T cells to express IL‐4Parasite Immunology, 2009
- Multifunctionality and mechanism of ligand binding in a mosquito antiinflammatory proteinProceedings of the National Academy of Sciences, 2009
- Ticks produce highly selective chemokine binding proteins with antiinflammatory activityJournal of Experimental Medicine, 2008